Live Chart

O 373

H 373

L 373

VOL 993

Laurus Labs Performance

Days Range

Low: ₹372.00
High: ₹376.75
Previous Close ₹370.75
Open ₹373.00
Volume 9,48,858
Day’s Range ₹372.00 - ₹376.75
52W Range ₹278.85 - ₹457.90
Market Cap ₹19,962 Cr

Fundamentals of Laurus Labs

ROCE (TTM) 10.94%
P/E Ratio (TTM) 54.26
P/B Ratio 4.95
Industry P/E 31.64
Debt to Equity 0.53
ROE 9.13%
EPS (TTM) 6.83
Dividend Yield 0.54%
Book Value 75
Face Value 2

Financials of Laurus Labs

Dec 2022Mar 2023Jun 2023Sep 2023
Net Sales1,544.821,380.91,181.791,224.45
Profit before tax277.85147.1440.5853.89
Operating Profit203.06107.2428.439.32
Net Profit203.06107.2428.439.32
EPS in Rs3.781.90.460.69

About Laurus Labs

Laurus Labs is a science-led, fully integrated pharmaceutical and biotechnology manufacturing company with a leadership position in generic active pharmaceutical ingredients (APIs) in selected high-gr ... Read More

Parent Organisation Indian Private
Founded 2005
Managing Director M V G Rao

Peer Comparison

Stocks Market Cap (cr) Market Price (₹) 52 Week Low-High (₹)
Supriya Lifescience Ltd ₹2,251.51


1.90 (0.68%)

277.5 - 285
Celestial Biolabs Ltd ₹4.56


0.00 (0.00)

1.75 - 1.8
JFL Life Sciences Ltd ₹48.39


0.50 (-1.14%)

43.5 - 43.5
Procter & Gamble Health Ltd ₹8,588.67


5.10 (0.10%)

5136.05 - 5190
Veerhealth Care Ltd ₹36.14


0.00 (0.00)

26 - 26

What's Trending


What is the Share price of Laurus Labs (LAURUSLABS)?

Laurus Labs (LAURUSLABS) share price as of November 29, 2023, on NSE is Rs 375.80 (NSE) and Rs 375.50 (BSE) on BSE.

Can I buy Laurus Labs (LAURUSLABS) shares?

Yes, You can buy Laurus Labs (LAURUSLABS) shares by opening a Demat account with Angel One.

How do I buy Laurus Labs (LAURUSLABS) from Angel One?

Laurus Labs (LAURUSLABS) share can be brought through the following modes:
  1. Direct investment: You can buy Laurus Labs (LAURUSLABS) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Laurus Labs (LAURUSLABS) shares.

Is Laurus Labs a Debt free Company?

No, Laurus Labs is not a debt free company.

What is the main business of Laurus Labs?

The main business of Laurus Labs is to research, manufacture, and sell pharmaceutical and biotechnology-related products with a special emphasis on Hepatitis C, anti-retroviral, and oncology drugs. It also sells its generic APIs in 56 countries along with generic FDF.

Who are the promoters of Laurus Labs?

Some of the main promoters of Laurus Labs are M/s. NSN Holdings (Represented by its Managing Partner, Dr. Satyanarayana Chava), Chava Naga Rani, Satyanarayana Chava, Chunduru Venkata Lakshmana Rao, Venkata Ravi Kumar Vantaram, Hymavathi Vantaram, Rama Suryadevara, and Krishnaveni Vasireddi.

What are the Subsidiaries that comes under Laurus Labs?

The main subsidiaries that come under Laurus Labs are Laurus Generics Inc., USA, Sriram Labs Pvt. Ltd., Laurus Holdings Ltd., Laurus Ingredients Pvt. Ltd., Laurus Generics Gmbh, Laurus Generics SA (Pty) Ltd., and Laurus Bio Private Ltd. (formerly known as Richcore Lifesciences Pvt. Ltd.).